ArticleCancer immunology, immunotherapy : CII2024
Correction to: Dominant‑negative transforming growth factor‑β receptor‑armoured mesothelin‑targeted chimeric antigen receptor T cells slow tumour growth in a mouse model of ovarian cancer.
Ke Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.